Showing results (1221-1230 of 1,437) with videos related to
Sort By:
Pageof 144
The Journal of Experimental Medicine|December 16, 2015
Integrative genetic analysis of mouse and human AML identifies cooperating disease allelesMegan A Hatlen, Kanika Arora, Vladimir Vacic, et al.Nature Genetics|September 25, 2012
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisLambert Busque, Jay P Patel, Maria E Figueroa, et al.Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.The Journal of Pharmacology and Experimental Therapeutics|June 4, 2017
Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31Lita A Freeman, Stephen J Demosky, Monika Konaklieva, et al.Therapeutic Innovation & Regulatory Science|May 17, 2021
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master TrialLen Rosenberg, Hugh Levaux, Ross L Levine, et al.Blood|June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphomaJakub Svoboda, Susan R Rheingold, Saar I Gill, et al.Cancer Immunology Research|July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T CellsSaba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.Pageof 144